Wu B-Q, Cao Y, Bi Z-G
Department of Orthopedics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7548. doi: 10.26355/eurrev_202007_22189.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway, by B.-Q. Wu, Y. Cao, Z.-G. Bi, published in Eur Rev Med Pharmacol Sci 2017; 21 (14): 3185-3192-PMID: 28770967" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13139.
由于本文被怀疑存在研究不当行为，且通讯作者未对我们要求证明数据和图表原创性的请求做出回应，因此由吴BQ、曹Y、毕ZG发表于《欧洲医学与药理学评论》2017年；21(14):3185 - 3192 - PMID: 28770967的“通过阻断Wnt/β-连环蛋白信号通路抑制骨肉瘤对阿霉素的耐药性”一文已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/13139
